Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Compr Psychiatry. 2020 Aug 12;102:152199. doi: 10.1016/j.comppsych.2020.152199

Table 04.

Association of the SERT Gene Polymorphism with the Number of Lifetime Diagnoses

Grouping SERT
Carrier (ss+sl)
Individuals
Affected (%)		 SERT
Non-Carrier (II)
Individuals
Affected (%)		 Total
Number
Individuals
Affected
Association of SERT Carrier Status with Prevalence of One or More Diagnoses LP Diagnosis (N=628)
No Diagnosis LP 120 (44.9) 147 (55.1) 267
One or More Diagnosis LP 160 (44.3) 201 (55.7) 361
Totals 280 (44.6) 348 (55.4) 628
OR Unadjusted: 1.0 (0.85 - 1.4) p: 0.88 / OR Adjusted: 1.0 (0.7 - 1.4) p: 0.92
Association of SERT Carrier Status with Prevalence of Two or More Diagnoses LP Diagnosis (N=361)
One Diagnosis LP 82 (45.1) 100 (54.9) 182
Two or More Diagnosis LP 78 (43.6) 101 (56.4) 179
Totals 160 (44.3) 201 (55.7) 361
OR Unadjusted: 1.1 (0.7-1.6) p: 0.78 / OR Adjusted: 1.0 (0.7-1.6) p: 0.84

Table 04 displays the association of the SERT Gene Polymorphism with the Number of Lifetime Diagnoses. ORs were adjusted for gender, age, ethnicity, and marital status.